CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex Phase II Clinical Trial Update, page-37

  1. 2,883 Posts.
    lightbulb Created with Sketch. 718
    It's not cash flow positive. Look at their last quarterly ffs.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.